FSD Pharma Secures Sales License for Massive Production Facility


Ryan Allway

April 23rd, 2019

App, Exclusive, News, Top News


Canada’s cannabis industry has experienced tremendous growth over the past several years, following the legalization of medical and adult-use cannabis. In addition to growing domestic demand, the country’s move to federally regulate cannabis has opened the door for its licensed producers to export products around the world. These dynamics have made licensed producers a valuable addition to growth investment portfolios.

FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) became the latest licensed producer to possess both cultivation and sales licenses on April 22 after securing its cannabis sales license from Health Canada. With nearly four million sq. ft. of space in a former Kraft Foods plant in Cobourg, Ontario, the company is uniquely positioned to scale up and become one of the largest licensed producers in the country over the coming quarters.

Securing a Sales License

FSD Pharma has spent the past several years retrofitting a nearly four million sq. ft. former Kraft Foods facility that sits on 70 acres of land—including 40 acres primed for development. After securing its cultivation license on October 13, 2017, the company was awarded a cannabis sales license on April 22, 2019 by Health Canada. The move paves the way for the company to produce and sell cannabis grown at its facility.

The company’s business model hinges on strategic partnerships that operate within its massive facility. For example, the company’s partnership with Canntab Therapeutics Ltd. (CSE: PILL) provies 10,000 sq. ft. of space at its facility in exchange for a profit-sharing and royalty agreement. Canntab’s proprietary technology enables standardized medical cannabis extracts in extended release pill formats that are ideal for physicians

“The granting of our sales license allows FSD to serve the growing medicinal use markets in Canada,” said FSD Pharma President Zeeshan Saeed. “We intend to quickly scale up production at our current facility, while continuing to build out the plant to add additional grow capacity. In addition, our sales license opens the door for our partner Canntab Therapeutics to commence sales of its suite of novel cannabis oral delivery platforms.”

Near-term & Long-term Potential

FSD Pharma’s new cannabis sales license creates a near-term revenue opportunity for shareholders. Under its partnership with Canntab and others, the company is entitled to a share of revenue that could begin in the very near-term. The company’s wide range of strategic partnerships could help diversify revenue and limit capital expenditures compared to many other licensed producers that invest in their own equipment and operations.

In addition to this near-term potential, the company has made a number of blue sky investments in the cannabis industry. A great example is the company’s recent letter of intent with Solarvest (TSX-V: SVS) to develop and test a way to create pharmaceutical-grade cannabinoids out of algae. If successful, this approach could dramatically increase production capacity without nearly as much overhead as conventional growing operations.

The company also announced an entry into the lucrative hemp industry with a 3-way supply agreement to purchase up to 1,000 kilograms of hemp crop for CBD extraction. The deal could open the door to hemp-based CBD products that can be more widely distributed across numerous different countries that haven’t legalized medical or recreational cannabis, including parts of the United States and Europe.

Looking Ahead

FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) reached a critical milestone by securing a cannabis sales license. With the potential for near-term revenue, investors may want to take a closer look at the stock over the coming months. At the same time, the company’s long-term investments could prove game-changers in the rapidly evolving industry.

For more information, visit the company’s website at www.fsdpharma.com.

Disclaimer

The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/

Ryan Allway

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media

CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.

CFN launched in June of 2013 to initially serve the growing universe of publicly traded marijuana companies across North America. Today, CFN Media is also the digital media choice for the emerging brands in the space.

Learn How Your Company can Be Covered on CFN Media

Learn More About the CFN Media Sponsored Content Program

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © TDM Financial LLC · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading